BrUOG L301: Xofigo Following Frontline-Line Chemotherapy For Patients With Non-Small Cell Lung Cancer and Bone Metastases
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 24 Apr 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 24 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018.